Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis

Yi Li(Zhengzhou Central Hospital), Jun Li(Sun Yat-sen University), Hongle Li(Shanghai Jiao Tong University), Bing Wei(Henan University of Engineering), Xia Xue(Fifth Affiliated Hospital of Zhengzhou University)
Cancer Biology and Medicine
October 9, 2023
10.20892/j.issn.2095-3941.2023.0177
Cited by 19

Related Papers

MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
SETD2: an epigenetic modifier with tumor suppressor functionality
|Oncotarget|2016|167
LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis
|Biomedicine & Pharmacotherapy|2019|72
IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis
|Journal of Experimental & Clinical Cancer Research|2022|64
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives
|Biomarker Research|2022|58